1. INSTITUT DE RECHERCHES CLINIQUES DE MONTRÉAL
Affiliated with the Université de Montréal
2010-2011 ANNUAL REPORT
1

2. THE IRCM
a leading biomedical research institute
located in the heart of Montréal
Our priorities
institut de recherches cliniques de Montréal _ 2010-2011 annual report
Conquering cancer | Living with a
healthy heart | Fighting infectious
diseases | Understanding embryonic
development and the nervous system
| Exploring the complexity of biological
2 systems | Accelerating clinical research 3
| Participating in ethical debates

3. 35
researchers –
IRCM
research
institut de recherches cliniques de Montréal _ 2010-2011 annual report
professors
discovering
4
152
scientific
publications
5
$18.8 million
in research
funding

4. 20,000 yearly visits at
the IRCM clinic
institut de recherches cliniques de Montréal _ 2010-2011 annual report
40
6 health
professionals
treating
7
20
physicians
specialized in
hypertension,
cholesterol,
obesity and
diabetes

5. 7
core
institut de recherches cliniques de Montréal _ 2010-2011 annual report
facilities
8
innovating
5
specialized
services
9
3
research
platforms

6. 7
institut de recherches cliniques de Montréal _ 2010-2011 annual report
new
declarations of
contributing
invention
10 11
11
new patent filings
(or applications)

7. 113
}
Master’s
and PhD
students
57
institut de recherches cliniques de Montréal _ 2010-2011 annual report
61
61 scholarship
holders
training
postdoctoral
fellows
12 13
408* teaching
hours
* at the Université de Montréal
316 hours
(25 of our researchers)
at McGill University
92 hours
(13 of our researchers)

8. institut de recherches cliniques de Montréal _ 2010-2011 annual report
Independent non-profit institution
Founded in
Affiliated with the Université de
1967
Montréal
Associated with McGill University
IRCM Clinic affiliated with the
Centre hospitalier de l’Université
de Montréal (CHUM)
14 15
425
Funded by Quebec ministry
of Economic Development,
Innovation and Export Trade
(MEDIE)
Supported by the Fonds de
researchers, students and employees recherche du Québec – Santé
38
(FRQS)
Member of the Université
de Montréal’s RUIS (Réseau
A budget of million dollars universitaire intégré de santé)
Dr. Jacques Genest, founder of the IRCM, surrounded by doctors from Montréal’s Hôtel-Dieu

9. MISSION
institut de recherches cliniques de Montréal _ 2010-2011 annual report
2011
To understand the causes of diseases
To find diagnostic tools and means of prevention
and treatment
16 17
To train a new generation of high-calibre
scientists
To contribute to Quebec’s socio-economic
development by facilitating the commercial
development of new discoveries

10. Messages from management 19
Planning the future 26
discovering
Research programs 29
treating
IRCM Clinic 45
innovating
Core facilities and technology platforms 55
institut de recherches cliniques de Montréal _ 2010-2011 annual report
contributing
Technology transfer 59
training
Tomorrow’s researchers 63
participating
18 Science for all 73 19
Research funding 77
Administration 78
IRCM Board of Directors 80
IRCM Management 82
Organizational charts 86
Financial statements 88
IRCM Foundation 90
Messages from management 99
supporting
Benefit activities 103
volunteering
IRCM Foundation Board of Directors
Give for Life campaign Board
107
108
Messages
giving
The impact of your donations
Partners and donors 116
Research Funds and Chairs
111
123
from management

11. 20
institut de recherches cliniques de Montréal _ 2010-2011 annual report
21

12. Message new laboratories and a new clinic, two new Board members: Monique Message a PhD in bioinformatics and who is
review of our governance rules and Jérôme-Forget, an important figure STRATEGIC PLANNING currently working as a postdoctoral
from the Chairman revision of our bylaws, in-depth in Quebec’s political scene and from the President fellow at the Dana-Farber Cancer
of the Board review of our affiliation contract with currently Special Advisor at Osler, and Scientific When the Board of Directors Institute and Harvard Public School
the Université de Montréal, creation Hoskin & Harcourt, and Michel adopted our strategic plan, we of Health in Boston. He will join
This message will be my last of the ombudsman position and Lespérance, a lawyer who pursued Director quickly got to work to set up the the institute in January 2012 as
as Chairman of the Institut de appointment of its first title-holder, his career at the Université de elements required for us to complete Assistant IRCM Research Professor
establishment of a Communications Montréal. The year 2010-2011 was marked by all measures planned for 2010- and Director of the Bioinformatics
recherches cliniques de Montréal’s
Committee to improve the Institut’s the implementation of the elements 2015. It is my pleasure to present and Computational Genomics
Board of Directors. After six
visibility. required to carry out the projects to you, in the following pages, the research unit. His laboratory will be
wonderful years chairing this Board,
On behalf of the entire management defined by our 2010-2015 strategic challenges of this strategic plan. part of the IRCM’s Systems Biology
the time has come for me to pass on
Following the IRCM’s 40th team and all Board members, I plan. and Medicinal Chemistry research
institut de recherches cliniques de Montréal _ 2010-2011 annual report
the torch.
anniversary, which we celebrated in wish to sincerely thank Claude A. RECRUITMENT program.
2007 in the presence of its founder, Garcia, who left after serving on Before presenting you with a report
With Louise Lambert-Lagacé now
Dr. Jacques Genest, we launched the Board for numerous years, for of this year’s activities, I would like I was honoured to welcome two INSTITUTIONAL FILES
at the helm, I am confident it is in
a major fundraising campaign his contributions and continued to take this opportunity to sincerely new researchers this year. Hua Gu,
excellent hands.
in collaboration with the IRCM commitment, particularly on the Audit thank Gérard A. Limoges, outgoing with a PhD in genetics from the Website
Foundation that will continue until Committee. Chairman of the IRCM’s Board of University of Cologne in Germany Our management team, as well as
During my time on the IRCM’s Board,
2015. Directors. and Professor of immunology at employees in the Communications
I have had the pleasure to meet
outstanding individuals: passionate Thank you to everyone and long live Columbia University before his and Information Technology
22 Finally, I had the pleasure of the IRCM! THANK YOU TO arrival at the Institut, is now Full departments, persistently worked 23
researchers, devoted nurses and
confirming the renewal of Dr. Tarik GÉRARD A. LIMOGES IRCM Research Professor, holder on the development and launch of
doctors, promising students and
postdoctoral fellows, knowledgeable Möröy’s term of office as President of the André-Aisenstadt Chair of our new website. Today, we are very
and Scientific Director. Since his Gérard A. Limoges, C.M., FCA For five years, I have had the Excellence, and Director of the new happy to offer a website with a new
and hard-working management
arrival, he has shown remarkable pleasure of working with Gérard, Molecular Immunology research look and user-friendly appearance:
and staff members. With them, I
leadership skills that have been an energetic man who truly cares unit. He is part of the Immunity and www.ircm.qc.ca.
have shared the pride of belonging
evidently reflected in all sectors of for the future of the Institut. In fact, Viral Infections research program.
to a prestigious institution known
activity at the Institut, and which I the summary of accomplishments Jennifer Estall, who received a IRCM’s evaluation by the FRSQ
the world over for the quality of
would hereby like to recognize. included in his message accurately PhD in molecular biology from Following a visit in February 2011
its research, and one where a
describes his commitment to our the University of Toronto and who by the Fonds de recherche en santé
stimulating and convivial environment
ACKNOWLEDGMENTS institution. I am very grateful for was a postdoctoral fellow at the du Québec (FRSQ), known today as
prevails.
his warm welcome upon my arrival, Dana-Farber Cancer Institute and the Fonds de recherche du Québec
I would like to earnestly thank my as well as for the support he has Harvard Medical School in Boston, is – Santé (FRQS), we received our
MY TIME AT THE INSTITUT
colleagues on the Board of Directors provided me over the past five years. currently Assistant IRCM Research research centre’s evaluation report
for their support. I wish them success I would therefore like to thank him Professor and Director of the and are extremely proud of its
I think I can rightly congratulate
in the pursuit of their respective personally, and on behalf of everyone Molecular Mechanisms of Diabetes results, the conclusions of which led
myself for what we accomplished
mandates under the chairmanship at the IRCM. On behalf of us all, on research unit in the Cardiovascular the evaluation committee’s chairman
during my chairmanship: revision
of Louise Lambert-Lagacé who will, whom Gérard has made a lasting and Metabolic Diseases research to qualify the IRCM as a “jewel
of the Institut’s legal status,
undoubtedly, perform her duties impression, I wish him success in the program. I also had the pleasure of Quebec” and recommend the
implementation of a new alliance
with characteristic effectiveness and future and, once again, thank you. of announcing the recruitment of restitution, or even the increase, of
with Univalor to support the transfer
of our technologies, inauguration of enthusiasm. I welcome the arrival of Benjamin Haibe-Kains, who obtained the IRCM’s funding. This is excellent

13. news, as this financial support is the Cardiovascular and Metabolic by the Montreal Council on Foreign
crucial to the proper functioning of Diseases research program. Jean- Relations (MCFR). It was a great
our institute. François Côté was appointed opportunity for me to share my
Associate Director of scientific concerns about research funding in
Agreement with McGill activities in the Academic Affairs general, and particularly in Canada. I
University office. I thank him for accepting this would like to thank Pierre Lemonde,
new challenge and also thank Benoit MCFR’s President and CEO, for
Historically, the Institut and McGill Coulombe who previously held the inviting me to this prestigious
University have engaged in an title. platform.
informal arrangement, by which
IRCM researchers, holding an RESEARCH PROGRAM CHANGES In closing, I would like to note that,
adjunct professor status in McGill’s once again this year, our researchers
institut de recherches cliniques de Montréal _ 2010-2011 annual report
Faculty of Medicine, held certain The year 2010-2011 saw numerous obtained excellent results in their
privileges allowing them to supervise changes in the IRCM’s research grant applications, especially those
graduate students registered at the programs. Some of our researchers for the Canadian Institutes of Health
University. I am pleased to announce retired while others reoriented Research (CIHR) where their
that an agreement has now been their scientific careers to hold new success rate was high above the
formalized by way of an official letter, positions, either within the Institut national average.
signed by both institutions – McGill or in prestigious research centres
University and the IRCM – and abroad. I wish to thank them for Finally, I want to thank the entire
24 now includes the supervision of their work and accomplishments at IRCM community, researchers, 25
postdoctoral fellows registered at the the IRCM and for the quality of their students, employees and Board
University. research projects. members, for their commitment and
dedication. Each in our own way, we
INTERNAL APPOINTMENTS GIVE FOR LIFE MAJOR are contributing to our institution’s
FUNDRAISING CAMPAIGN development and success.
Management changes were made
in the Academic Affairs department. The IRCM Foundation’s major Tarik Möröy, PhD
Timothy L. Reudelhuber accepted fundraising campaign continues.
to become the new Executive Many donations have been
Director of Academic Affairs. As confirmed. In this respect, I would
such, he became a part of the like to thank everyone who supports
Institut’s administrative management the Institut. Your contribution is very
team and a member of the important.
Management Committee. He is
also responsible for the academic MEETING THE BUSINESS
staff. I wish to thank him, as well COMMUNITY
as Christian F. Deschepper who
held the position over the past few I was privileged to meet members
years. Dr. Deschepper took over of Montréal’s business community
for Dr. Reudelhuber as Director of when I spoke at a conference held

14. Clinical research boost A new and innovative training program for international
graduate students has been submitted to the Université
Boosting clinical research requires collaboration between de Montréal, and planning is underway at the IRCM for its
basic science researchers and clinical researchers in implementation.
a synergistic approach. To achieve this, we must better
support and accelerate communication between basic Strategic Projects Advisor
and clinical research by exploiting their complementarity.
The IRCM created the position of Strategic Projects
An ad hoc committee was created in partnership with Advisor, which will be held by Martin Godbout, former
CHUM to make recommendations for a clinical and President and CEO of Genome Canada. He will assist
institut de recherches cliniques de Montréal _ 2010-2011 annual report
translational research model including appropriate the Institut in developing projects for extensive strategic
performance indicators and conditions for success. grant applications. His services will also enable the IRCM
and its scientists to identify new funding possibilities and
Creation of a formal hospital alliance seize opportunities that might otherwise be lost.
with CHUM
Successful clinical and translational research at the Scientific Advisory Board
IRCM must assuredly involve increased access to a
26 hospital environment and clinical researchers. Thus, a A Scientific Advisory Board, chaired by Alan Bernstein, 27
formal alliance with the Centre hospitalier de l’Université has been formed. Made up of seven members, this
de Montréal (CHUM) as a main partner in clinical committee’s main objective will be to advise the Institut on
research will give both organisations an important its scientific orientation, clinical and translational research,
In recent years, the field of life sciences saw major transformations, as strategic advantage. For the IRCM, CHUM will offer technology transfer strategies and means of forging
privileged access to a clinical environment and patients successful alliances with other research institutions.
well as a rapid and substantial expansion in Quebec and Canada. Analysis of with complex medical conditions, as well as a potential This committee will also conduct a full institutional and
the Institut’s recent evolution, in parallel with that of biomedical research, pool of clinical researchers. For its part, the IRCM will scientific review of the IRCM every five years.
provide CHUM with its world-renowned expertise in basic
allowed for certain observations and led us to conduct a strategic planning science and its modern research equipment. comMiTTEE MEMBERS: Alain Bernstein, Chair; John Aitchison (Institute
for Systems Biology, USA); Peter Bruns (Howard Hughes Medical Institute,
exercise. USA); Gordon Fishell (New York University, USA); Paul Frenette (Albert
Consolidation of our alliance with the
Einstein College of Medicine, USA); Roderick R. McInnes (Lady Davis
Université de Montréal and training Research Institute, Canada); Walter Rosenthal (Max-Delbrück Center for
PLANNING
prioritisation Molecular Medicine, Germany); Alfred Singer (National Cancer Institute,
USA).
The IRCM must consolidate its university affiliation
with the Université de Montréal in order to maximize
collaboration between the Université and the Institut,
THE FUTURE
and reassert its position as a leading research centre for
graduate studies.

15. The Institut de recherches cliniques de Montréal was the
first research centre in Quebec to bring together basic
science researchers and clinical researchers
under one roof, thereby becoming the forerunner for
institut de recherches cliniques de Montréal _ 2010-2011 annual report
translational research centres.
-- 5
discovering
research programs
- 35
28
152
research units
*
scientific publications
29
262
*
researchers and clinicians
39 laboratories were operational in 2010-2011
**
** including postdoctoral fellows and students - August 31, 2011

16. institut de recherches cliniques de Montréal _ 2010-2011 annual report
“In 2010, we published the results of a study in the scientific journal Current
Biology, from the Cell Press group, which demonstrates that a key mechanism
in the control of cell motility could eventually lead to the development of
new cancer-treating drugs that could block the spread of tumours. As many
as 90% of cancer patient deaths are attributable to metastasis, which explains
30 the importance of understanding the molecular mechanisms at the basis of this 31
harmful process.”
JEAN-FRANÇOIS CÔTÉ, PhD
Associate IRCM Research Professor
Director of the Cytoskeletal Organization and Cell Migration research unit
Jean-François Côté, Nadine Fradet, research assistant, and Manishha Patel, doctoral student

17. “In our laboratory, much like many other scientists around the world, we are
institut de recherches cliniques de Montréal _ 2010-2011 annual report
trying to uncover our nervous system’s innumerable mysteries. Our work focuses
on motor neurons, which control muscles and are located in the spinal cord.
Recently, we discovered a new piece of the puzzle in the development of our
nervous system, which was published in the scientific journal Neuron of the Cell
Press group. Our experiments shed light on poorly-understood mechanisms of
32 neuronal development. In fact, our breakthrough offers the scientific community a 33
new basis for explaining how the function of very few molecules can be modulated
to produce a vast array of neuronal connections.”
ARTUR KANIA, PhD
Associate IRCM Research Professor
Director of the Neural Circuit Development research unit
Artur Kania and Tzu-Jen Kao, postdoctoral fellow

18. CONQUERING
Cancer research program
“The Cancer research program brings together researchers interested in basic cell
CANCER
proliferation and signalling mechanisms, breast cancer and tumor suppressor genes,
leukemia and lymphoma, tumour angiogenesis, cell migration and metastasis.
The general research objective of our program’s members is to understand the
molecular mechanisms governing the neoplastic process, such as normal and
Research units pathological hematopoiesis, ciliopathies, cell motility and dissemination, and
signalling in normal and cancerous epithelial and endothelial cells. Projects in
institut de recherches cliniques de Montréal _ 2010-2011 annual report
Jean-François Côté, PhD – Director, Cytoskeletal Organization and
marie trudel
Cell Migration – Associate IRCM Research Professor this research program aim to discover new molecular targets and develop new
Jean-Philippe Gratton, PhD – Director, Endothelial Cell Biology therapeutic approaches and/or molecules to counter cancer progression.”
– Associate IRCM Research Professor – Canada Research Chair in
Endothelial Cell Signalling and Angiogenesis MARIE TRUDEL, PhD
Tarik Möröy, PhD – Director, Hematopoiesis and Cancer – Full IRCM Director of the Cancer research program
Research Professor – Canada Research Chair in Hematopoiesis and Full IRCM Research Professor
Immune Cell Differentiation Director of the Molecular Genetics and Development research unit
34 35
Katrina Podsypanina, MD, PhD – Director, Breast Cancer Biology –
Assistant IRCM Research Professor
Marie Trudel, PhD – Director, Molecular Genetics and Development
– Full IRCM Research Professor
William Y. Tsang, PhD – Director, Cell Division and Centrosome
Biology – Assistant IRCM Research Professor
Jean Vacher, D.Sc. – Director, Cellular Interactions and Development
2010-2011
– Full IRCM Research Professor
7 teams 2 scholarship holders from the Fonds de recherche
du Québec – Santé (FRQS): Jean-François Côté and
“Projects in this research program aim 2 Canada Research Chairs
17 publications by the program’s researchers
William Y. Tsang
to discover new molecular targets and 1 researcher honoured: Tarik Möröy was selected by
1 New Investigator Award from the Canadian Institutes of
Health Research (CIHR): William Y. Tsang
develop new therapeutic approaches Canadians for Health Research (CHR) as Researcher
of the Month in January 2011. 6 operating grants from the Canadian Institutes of Health
and/or molecules.” CHR is a national organisation dedicated to promoting health
research in Canada.
Research (CIHR), 3 recipients, $3.2 million: Jean-
Philippe Gratton, Tarik Möröy, William Y. Tsang

19. LIVING WITH
Cardiovascular and Metabolic Diseases research program
“The cardio-metabolic research program groups together researchers working
A HEALTHY
on the biology of cardiovascular diseases and diabetes. Collectively, our projects
lead to a better understanding of risk factors for cardiovascular diseases, including
genetic factors, hypertension, dyslipidemia, endothelial cell dysfunctions and
HEART metabolic disorders. This research is conducted by basic researchers as well as
clinical researchers, thereby increasing the clinical relevance of our work. This
institut de recherches cliniques de Montréal _ 2010-2011 annual report
year, our research program was enriched by the arrival of Dr. Jennifer Estall,
CHRISTIAN F. DESCHEPPER
Research units allowing us to benefit from her expertise in the molecular pathophysiology of
Christian F. Deschepper, MD – Director, Experimental type-2 diabetes.”
Cardiovascular Biology – Full IRCM Research Professor
Louis-Gilles Durand, O.Q., PhD, ing. – Director, Biomedical CHRISTIAN F. DESCHEPPER, MD
Engineering (laboratory closed on December 31, 2010) Director of the Cardiovascular and Metabolic Diseases research program
Full IRCM Research Professor
Jennifer Estall, PhD – Director, Molecular Mechanisms of Diabetes
36 Director of the Experimental Cardiovascular Biology research unit 37
– Assistant IRCM Research Professor
Pierre Larochelle, MD, PhD, FRCPC, FACP, FAHA – Director,
Cardiovascular Pharmacology
Claude Lazure, PhD – Director, Neuropeptide Structure and
Metabolism – Full IRCM Research Professor
Rémi Rabasa-Lhoret, MD, PhD – Director, Metabolic Diseases –
J.A. DeSève Chair of Excellence
2010-2011
Timothy L. Reudelhuber, PhD – Director, Molecular Biochemistry
of Hypertension – Full IRCM Research Professor
M. Ram Sairam, PhD – Director, Molecular Endocrinology – Full
IRCM Research Professor
Nabil G. Seidah, C.M., O.Q., PhD, MSRC – Director, Biochemical
10 teams 2 researchers honoured: Pierre Larochelle is appointed
Neuroendocrinology – Full IRCM Research Professor – Canada
Professor Emeritus, a rare honour granted by the
Research Chair in Precursor Proteolysis
1 Canada Research Chair Université de Montréal; and Timothy L. Reudelhuber is
Gaétan Thibault, PhD – Director, Cellular Biology of Hypertension honoured by the American Heart Association’s Council
(laboratory closed on January 31, 2011) 1 IRCM Research Chair for High Blood Pressure Research as honorary speaker
for the 2010 Arthur C. Corcoran Memorial Lecture
56 publications by the program’s researchers
1 grant of $20,000 from Diabetes Québec: Rémi
Rabasa-Lhoret

20. FIGHTING
Immunity and Viral Infections research program
“The Immunity and Viral Infections research program integrates researchers
INFECTIOUS
interested not only by the development of immune cells and the regulation of
their functions, but also by viral infections, especially those involving viruses
that infect immune cells. The scientific mission of our research program is
DISEASES
to understand the signalling mechanisms that play an important role in the
development, the function and the diseases of the immune system as well as to
explore how viral infections, namely HIV/AIDS, lead to immune dysfunctions.
institut de recherches cliniques de Montréal _ 2010-2011 annual report
Éric A. Cohen
Collectively, our studies have led to a better understanding of immune cell
Research units regulation in normal and pathological conditions such as during autoimmune
Éric A. Cohen, PhD – Director, Human Retrovirology – Canada Research Chair diseases, viral infections and immunodeficiency. This year, Dr. Hua Gu, a
in Human Retrovirology renowned senior immunologist, joined our research program. Dr. Gu’s work on
Vibhuti P. Dave, PhD – Director, Lymphocyte Development (laboratory closed
on December 31, 2010)
antitumor immunotherapy will help strengthen our translational research.”
38 39
Javier Marcelo Di Noia, PhD – Director, Mechanisms of Genetic Diversity ÉRIC A. COHEN, PhD
– Associate IRCM Research Professor – Canada Research Chair in Genetic Director of the Immunity and Viral Infections research program
Diversity Director of the Human Retrovirology research unit
Hua Gu, PhD – Director, Molecular Immunology – Full IRCM Research Professor Canada Research Chairholder in Human Retrovirology
– André-Aisenstadt Chair of Excellence in Immunology
Paul Jolicoeur, MD, PhD, MSRC – Director, Molecular Biology – Full IRCM
Research Professor – Canada Research Chair in Studies of Pathogenesis of
Retrovirus-Induced Diseases
Woong-Kyung Suh, PhD – Director, Immune Regulation – Assistant IRCM
Research Professor
2010-2011
André Veillette, MD, MSRC – Director, Molecular Oncology – Full IRCM
Research Professor – Canada Research Chair in Immune System Signalling
“our studies have led to a better 7 teams 17 publications by the program’s researchers
understanding of immune cell 3 Canada Research Chairs 1 operating grant from the Canadian Institutes of Health
regulation in normal and pathological 1 IRCM Research Chair
Research (CIHR), $700,000: Éric A. Cohen
conditions...”

21. UNDER-
Neurobiology and Development research program
Understanding embryonic development and the nervous system
Participating in ethical debates
STANDING “Researchers in the Neurobiology and Development research program focus their
efforts on understanding the cellular and molecular mechanisms that control the
THE NERVOUS
development of different organs. Certain groups are interested in mechanisms
controlling cell proliferation, differentiation, polarity and death during the
development of the nervous system, pituitary gland, limbs, bones, kidneys and
institut de recherches cliniques de Montréal _ 2010-2011 annual report
SYSTEM
michel cayouette epithelial tissues, while others study hormone action mechanisms or guidance
mechanisms that allow axons to find their target within a complex neural network.
One of our teams also explores ethical questions related to neurosciences. Hence,
our researchers’ work is based on simple reasoning: in order to better understand
the pathology of diseases and develop effective therapeutic strategies, it is
40 Research units absolutely necessary to know, in detail, the mechanisms that control the normal 41
Michel Cayouette, PhD – Director, Cellular Neurobiology – Associate development of our organs. The knowledge acquired should thereby have a major
IRCM Research Professor impact on diagnostic, prevention and treatment strategies.”
Frédéric Charron, PhD – Director, Molecular Biology of Neural
Development – Associate IRCM Research Professor MICHEL CAYOUETTE, PhD
Jacques Drouin, D.Sc., MSRC – Director, Molecular Genetics – Full IRCM Director of the Neurobiology and Development research program
Research Professor Associate IRCM Research Professor
Director of the Cellular Neurobiology research unit
David R. Hipfner, PhD – Director, Epithelial Cell Biology – Assistant
IRCM Research Professor
Marko Horb, PhD – Director, Molecular Organogenesis (laboratory closed
2010-2011
on June 1, 2011)
Artur Kania, PhD – Director, Neural Circuit Development – Associate
IRCM Research Professor
Marie Kmita, PhD – Director, Genetics and Development – Assistant
IRCM Research Professor – Canada Research Chair in Molecular
8 teams 3 operating grants from the Canadian Institutes of Health
Embryology and Genetics
Research (CIHR), $1.6 million: Michel Cayouette,
Éric Racine, PhD – Director, Neuroethics – Associate IRCM Research 1 Canada Research Chair
Jacques Drouin, Marie Kmita
Professor 36 publications by the program’s researchers
1 grant of $120,000 from the Cancer Research Society:
1 scholarship holder from the Fonds de recherche du Frédéric Charron
Québec — Santé (FRQS): Michel Cayouette
1 grant of $45,000 from Parkinson Society Canada:
1 New Investigator Award from the Canadian Institutes Jacques Drouin
of Health Research (CIHR): David R. Hipfner